Amgen and its subsidiary, Onyx Pharmaceuticals, have submitted a supplemental New Drug Application (sNDA) to the FDA for their proteasome inhibitor, carfilzomib (Kyprolis), in the hopes of expanding the drug's indication to include patients with relapsed multiple myeloma who have received at least 1 prior therapy.
An examination of the pathophysiology of asthma.
Thomas Morrow, MD, chief medical officer at Next IT, discusses the future of patient care with the use of virtual health assistants.
Technology locates tumors otherwise obscured by dense breast tissue on a mammogram.
Strong association found between corticosteroids and risk of venous thromboembolism.
A review of the pathology of asthma and COPD, including the role of the immune system, along with the mechanisms behind the hypercapnia and hypoxemia of COPD, and the blue bloater vs. pink puffer pseudodichotomy.
Smokers have greater risk for recurrence of cancer.
Daily fixed-dose combination tablet contains 800 mg of darunavir and 150 mg of cobicistat.
Cost and cold chain concerns drive a decrease in shipping via air freight.
Use of a hormonal contraceptive for at least 5 years linked to potential increase in development of glioma of the brain.
Repurposing drugs that block sodium channels may offer a novel therapy for cancer.
The FDA today approved Bristol-Myers Squibb Company's atazanavir and cobicistat for the treatment of HIV-1 infection in adults in combination with other antiretroviral agents.
Pharmacist collaboration with physicians during a national shortage of intravenous trimethoprim/sulfamethoxazole may have helped mitigate negative treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumonia.
The FDA today approved the expanded use of a breakthrough therapy for the treatment of a rare form of cancer that attacks the immune system.
System would provide more treatment options for patients along with evidence of drug safety and efficacy for regulators.
Kidneys transplanted from infant who died days after birth.
Pharmacists are getting closer to obtaining provider status, as federal legislation that would enable pharmacists to provide health care services to Medicare patients in underserved communities has been reintroduced in the US Senate and House of Representatives.
Benefits of tamoxifen varies among patients.
Researchers gain insight into the cause of fatigue in MS patients.
Vitamin D can stimulate the immune system to protect against a specific type of colorectal cancer.
Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developing trends in the limited distribution of specialty medications.
Researchers discover how cancer resists BRAF+MEK inhibitors.
Nine state region found to have lowest survival rates nationwide.
Eribulin evaluated for the first time as an early metastatic breast cancer treatment.
Chimeric antigen receptor may be able to treat a number of cancer types.
Pharmacists play an important role in ensuring optimal patient outcomes within accountable care organizations.
Popularity of new treatments lead to shrinking demand for Merck's Victrelis.
Pathway discovered that allows aggressive tumors to proliferate.
Protective effect less clear for cutaneous melanoma.
The Center for Pharmacy Practice Accreditation today announced the launch of a new accreditation program for specialty pharmacy practices. The application for accreditation and the newly approved specialty pharmacy accreditation standards are available at http://pharmacypracticeaccredit.org/.
